ADVFN - Advanced Financial Network.
HOME» NYSE » T » TLB Stock Price » TLB Stock News

Talbots Share News

 Talbots, Inc. Stock Price
TLB Stock Price
 Talbots, Inc. Stock Chart
TLB Stock Chart
 Talbots, Inc. Stock News
TLB Stock News
 Talbots, Inc. Company Information
TLB Company Information
 Talbots, Inc. Stock Trades
TLB Stock Trades

US HOT STOCK FUTURES: HOT STOCKS TO WATCH

Among the companies with shares expected to actively trade in Thursday's session are Lions Gate Entertainment Corp. (LGF), TiVo Inc. (TIVO) and Talbots Inc. (TLB). Lions Gate Entertainment swung to a fiscal fourth-quarter loss as the movie and television studio saw higher marketing and acquisition expenses overshadow soaring revenue from its two blockbuster young-adult series. Shares slid 3.5% to $12.40 premarket amid the surprise loss. TiVo swung to a fiscal first-quarter loss as litigation and marketing expenses rose, though the company reported an increase in subscribers. Shares slid 5.7% to $8.45 premarket as the company also issued a downbeat second-quarter outlook. Talbots agreed to be acquired by Sycamore Partners in a deal valued at about $193.3 million, far less than the struggling retailer stood to receive in a potential deal that fell apart last week. The struggling retailer's shareholders will receive $2.75 a share, down from the former offer of $3.05 a share. Shares more than doubled premarket to $2.58 after tanking in the wake of the failed bid. Leap Wireless International Inc.'s (LEAP) Cricket prepaid phone service will start selling Apple Inc.'s (AAPL) iPhone next month, making it the first prepaid carrier to offer the device in the U.S. Shares jumped 5.8% to $5.77 in premarket trade following the disclosure. Ciena Corp.'s (CIEN) fiscal second-quarter loss narrowed amid fewer acquisition and integration-related charges and as the network gear maker also posted stronger-than-expected revenue growth. Shares were up 6.7% at $12.68 in premarket trading as Ciena reported a surprise adjusted profit. Peer JDS Uniphase Corp. (JDSU) also traded up, gaining 0.7% to $10.07 premarket. Movado Group Inc.'s (MOV) fiscal first-quarter profit surged as the luxury watchmaker had robust sales growth of its accessible luxury and licensed-brand categories. Shares climbed 2.6% to $29.21 premarket. Joy Global Inc.'s (JOY) fiscal second-quarter earnings rose 32% as the mining equipment maker increased shipments in its core underground and surface mining businesses, helped by recent acquisitions. But while its results topped consensus, the company isn't terribly optimistic near-term, listing a litany of concerns ranging from slowing growth in China to the euro-zone woes to a lack of economic catalysts in the U.S. Shares slipped 1.9% to $57.76 premarket. F5 Networks Inc. (FFIV) said its head of worldwide sales, Executive Vice President Mark Anderson, resigned after about eight years with the network-equipment provider company. He was replaced by Dave Feringa, senior vice president for Americas sales. Shares dropped 3.7% premarket to $103.60 amid the departure. National Oilwell Varco Inc. (NOV) agreed to acquire CE Franklin Ltd. (CFK, CFT.T) for about C$231 million, giving the manufacturer of energy-production equipment a supplier of similar products. National Oilwell plans to pay C$12.75 per share for CE Franklin, a 36% premium over its Wednesday closing price on the Toronto Stock Exchange. CE Franklin's U.S.-traded shares jumped 35% to $12.25 premarket. Chelsea Therapeutics International Ltd. (CHTP) said a recent clinical study of its investigational rheumatoid arthritis treatment CH-4051 missed a primary endpoint and the small drug maker had no further plans to develop the medication. Shares fell 18% to $1.60 in premarket trading. BioMarin Pharmaceutical Inc. (BMRN) said it will offer 6.5 million shares and retained broad discretion on the use of the funds. Shares were down 4% at $36.76 premarket. Coldwater Creek Inc.'s (CWTR) fiscal first-quarter loss narrowed as the women's apparel retailer reported lower overhead costs and improved margins, though revenue fell more than expected. Shares rose 6.6% premarket to 90 cents. Watchlist: Biopharmaceutical firm Alkermes PLC (ALKS) said it won't advance its study of its opioid-induced constipation treatment, ALKS 37, after the drug failed to meet the company's goals in a recent trial. AptarGroup Inc. (ATR) has agreed to acquire the Stelmi Group, a maker of elastomer primary-packaging components for injectable drug delivery, for approximately EUR165 million ($207 million) in a deal that expands the dispenser maker's offerings for the pharmaceutical industry. AT&T Inc. (T) reached a tentative agreement for a one-year contract extension for nearly 7,000 core wireline workers, an agreement that comes before the contract expires on June 23. Endologix Inc. (ELGX) said it planned to offer 2.7 million shares, as the company looks to use the proceeds for general-corporate needs, which may include research and development and capital expenditures. MSCI Inc. (MSCI) said Chief Financial Officer David M. Obstler will resign to pursue other interests, and Robert Qutub was appointed to replace him. Noble Energy Inc. (NBL) agreed to sell its stake in certain properties in the U.K.'s North Sea to Maersk Oil North Sea Ltd. for about $127 million, as the oil-and-gas explorer continues to divest its noncore properties. NV Energy Inc. (NVE) on Wednesday said its Chief Financial Officer Dilek Samil would become chief operating officer, and named Caesars Entertainment Corp.'s (CZR) financial chief Jonathan Halkyard as its new CFO. Tengion Inc. (TNGN) said its board approved a 1-for-10 reverse stock split in an effort to raise the clinical-stage regenerative medicine company's per-share trading price above $1 to comply with Nasdaq listing requirements. Zumiez Inc. (ZUMZ) posted a 13.7% jump in May same-store sales while analysts expected a 6.6% rise. The company has been on a tear, delivering strong numbers as teenage consumers respond to its surfing- and snowboarding-related apparel. -Edited By Corrie Driebusch and Nathalie Tadena, Dow Jones Newswires; 212-416-2143; corrie.driebusch@dowjones.com

Stock News for Talbots (TLB)
DateTimeHeadline
03/12/201516:03:00TearLab Corporation Reports 2014 Financial Results
03/05/201508:00:00TearLab Announces $35 Million Term Loan Agreement With CRG
03/02/201516:30:00TearLab to Participate in the 27th Annual ROTH Conference
02/19/201508:30:00TearLab Corporation to Release Q4 and Full Year 2014 Financial...
02/06/201507:45:00TearLab Corporation Announces Inducement Grant Under NASDAQ Rule...
01/28/201508:00:00TearLab Appoints Raymond Kong as Vice President of Sales
08/11/201410:00:00Talbots Partners with National Breast Cancer Foundation in support...
07/16/201417:30:00TearLab Corporation to Release Q2 2014 Financial Results on August...
07/14/201416:15:00Manoj Venkiteshwar Joins TearLab as VP of Medical Affairs
06/13/201416:02:00TearLab Announces Election of Directors
05/21/201417:00:00TearLab to Participate in the 11th Annual Craig-Hallum Institutional...
05/08/201416:02:00TearLab Corporation Reports Q1-14 Financial Results
04/21/201416:15:00Accomplished International Ophthalmic Industry Executive Joins...
04/16/201416:30:00TearLab Corporation to Release Q1 2014 Financial Results on May...

Talbots and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad